Study details
Enrolling now
Individualized Adaptive Deep Brain Stimulation for Opioid Use Disorder
University of California, San Francisco
NCT IDNCT07214467ClinicalTrials.gov data as of Apr 2026
Target enrollment
6
Study length
about 6.1 years
Ages
22–75
Locations
1 site in CA
About this study
Researchers are testing whether personalized (adaptive) Deep Brain Stimulation (DBS) can help reduce cravings and opioid use in people with opioid use disorder. The trial will involve a device that is implanted to stimulate specific areas of the brain.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Deep Brain Stimulation
Primary goalIncidence of adverse events during aDBS phase
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Incidence of adverse events during aDBS phase, Incidence of adverse events during sEEG phase
Devices
implantable
Body systems
Psychiatry / Mental Health